ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/1-[(4R,5R)-4,5-Dihydroxy-L-ornithine]echinocandin B
C34H51N7O15
797.8 g/mol
APIWarning

Echinocandin B, 1-[(4R,5R)-4,5-dihydroxy-L-ornithine]-

CAS79411-15-7EC695-359-9
Category
API
Compound Class
Peptide
Primary Use
Pharmaceutical Raw Material

This compound is a macrocyclic peptide-like substance used as an antifungal active pharmaceutical ingredient. Its structure features multiple hydroxyl and amide groups, contributing to its high polarity and low lipophilicity.

antifungal pharmaceutical manufacturingresearch compound for antifungal studies

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Echinocandin B, 1-[(4R,5R)-4,5-dihydroxy-L-ornithine]-?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ApplicationSame Use

Itraconazole

CAS84625-61-6

pharmaceutical raw material

ApplicationSame Use

Liranaftate

CAS88678-31-3

pharmaceutical raw material

ApplicationSame Use

Terbinafine

CAS91161-71-6

pharmaceutical raw material

ApplicationSame Use

Isavuconazonium sulfate

CAS946075-13-4

pharmaceutical raw material

ReferenceSame Category

San 201-456

CAS79486-60-5

pharmaceutical raw material

ReferenceSame Category

Levocabastine

CAS79516-68-0

pharmaceutical raw material

ReferenceSame Category

Octreotide acetate

CAS79517-01-4

pharmaceutical raw material

ReferenceSame Category

Sertraline hydrochloride

CAS79559-97-0

pharmaceutical raw material

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Harmful
Harmful
Warning
H302Harmful if swallowed
Identifiers
IUPAC Name

18-amino-6-[1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis(1-hydroxyethyl)-26-methyl-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosane-2,5,8,14,17,23-hexone

InChIKey

BLKJKIJFNJAQIZ-UHFFFAOYSA-N

SMILES

CC1CN2C(C1O)C(=O)NC(C(CC(C(=O)NC(C(=O)N3CC(CC3C(=O)NC(C(=O)NC(C2=O)C(C)O)C(C(C4=CC=C(C=C4)O)O)O)O)C(C)O)N)O)O

Synonyms (4)
  • AM032999;AN-36548;PL011811

Sourcing Echinocandin B, 1-[(4R,5R)-4,5-dihydroxy-L-ornithine]-?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→